{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:05:35Z","timestamp":1784070335658,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Liposarcoma (LS) is the second most common histological subtype of soft tissue sarcoma, accounting for approximately 7% of all soft tissue sarcomas, among which retroperitoneal liposarcoma (RPLS) is not a rare clinical entity. While RPLS involving the kidney and requiring combined urological management is relatively uncommon with limited clinical reports, it is often asymptomatic in the early stage, with clinical symptoms appearing only when the tumor compresses adjacent organs. Surgical resection is the cornerstone of treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 54-year-old female was diagnosed with a well-differentiated giant retroperitoneal RPLS (250\u00a0mm \u00d7 92\u00a0mm) compressing the right kidney via contrast-enhanced MRI. After strict multidisciplinary evaluation in accordance with the 2024 NCCN Guidelines for Soft Tissue Sarcoma, preoperative core needle biopsy was not performed, and the retroperitoneal approach was selected for surgical intervention. On August 6, 2024, Da Vinci Xi Surgical System robot-assisted retroperitoneal tumor resection combined with right nephrectomy and retroperitoneal lymph node dissection was successfully completed via the retroperitoneal approach. Postoperative pathology and immunohistochemistry (MDM2 (+), S-100 (+), etc.) confirmed the diagnosis. The patient recovered uneventfully and was discharged on postoperative day 6 with individualized adjuvant targeted therapy. Follow-up CT scans at 3 months, 6 months, and 1 year postoperatively showed no tumor recurrence, and laboratory examinations such as serum creatinine were normal. This case preliminarily confirms the feasibility and safety of robot-assisted retroperitoneal approach for strictly selected giant RPLS (&gt;\u200920\u00a0cm) confined to the retroperitoneal space, and provides a standardized urological management reference for similar cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Most existing robot-assisted retroperitoneal liposarcoma (RPLS) surgeries are performed via the transabdominal approach, and the reported cases of retroperitoneal approach are limited to moderately sized tumors (diameter\u2009&lt;\u200910\u00a0cm). This case demonstrates the feasibility and safety of robot-assisted retroperitoneal approach for giant RPLS (&gt;\u200920\u00a0cm) strictly confined to the retroperitoneal space, expands the application scope of this approach, and provides a standardized urological management strategy for RPLS compressing the kidney for clinical reference.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12894-026-02186-2","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:47:09Z","timestamp":1779104829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Robot-assisted nephrectomy for retroperitoneal liposarcoma compressing the kidney: a case report with urological management perspective"],"prefix":"10.1186","volume":"26","author":[{"given":"Hao","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanwen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"issue":"2","key":"2186_CR1","doi-asserted-by":"publisher","first-page":"rjaf056","DOI":"10.1093\/jscr\/rjaf056","volume":"2025","author":"M Hassani","year":"2025","unstructured":"Hassani M, Deflaoui T, Derkaoui A, et al. Surgical management of giant retroperitoneal liposarcoma: a case report and review of the literature. J Surg Case Rep. 2025;2025(2):rjaf056.","journal-title":"J Surg Case Rep"},{"key":"2186_CR2","doi-asserted-by":"publisher","first-page":"101950","DOI":"10.1016\/j.suronc.2023.101950","volume":"49","author":"E Brehat","year":"2023","unstructured":"Brehat E, Chaltiel L, Thoulouzan M, et al. Survival analysis and prognostic factors of retroperitoneal liposarcoma curative surgery in a single centre. Analysis of adjacent organ invasion between imaging and definitive histopathology. Surg Oncol. 2023;49:101950.","journal-title":"Surg Oncol"},{"key":"2186_CR3","doi-asserted-by":"publisher","first-page":"1414780","DOI":"10.3389\/fonc.2024.1414780","volume":"14","author":"Q Hao","year":"2024","unstructured":"Hao Q, Cha L, Zhou B, et al. Da Vinci robot-assisted retroperitoneal tumor resection in 105 patients: a single-center experience. Front Oncol. 2024;14:1414780.","journal-title":"Front Oncol"},{"issue":"1","key":"2186_CR4","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1186\/s12885-024-12629-4","volume":"24","author":"DN Liu","year":"2024","unstructured":"Liu DN, Yan L, Li ZW, et al. Optimizing surgical strategies for retroperitoneal liposarcoma: a comprehensive evaluation of standardized aggressive surgical policies. BMC Cancer. 2024;24(1):855.","journal-title":"BMC Cancer"},{"issue":"7","key":"2186_CR5","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1158\/1078-0432.CCR-24-2531","volume":"31","author":"C Wang","year":"2025","unstructured":"Wang C, et al. Anlotinib versus placebo as adjuvant therapy for localized high-grade soft-tissue sarcomas: a phase II, double-blinded, randomized controlled trial. Clin Cancer Res. 2025;31(7):1194\u2013203.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2186_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1200\/JCO.2017.74.9598","volume":"36","author":"ATJ Lee","year":"2018","unstructured":"Lee ATJ, Thway K, Huang PH, et al. Clinical and molecular spectrum of liposarcoma. J Clin Oncol. 2018;36(2):151\u20139.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2186_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1148\/radiol.2241011113","volume":"224","author":"MJ Kransdorf","year":"2002","unstructured":"Kransdorf MJ, Bancroft LW, Peterson JJ, et al. Imaging of fatty tumors: distinction of lipoma and well-differentiated liposarcoma. Radiology. 2002;224(1):99\u2013104.","journal-title":"Radiology"},{"key":"2186_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13566-012-0085-0","volume":"2","author":"A Betgen","year":"2013","unstructured":"Betgen A, Haas RLM, Sonke JJ. Volume changes in soft tissue sarcomas during preoperative radiotherapy of extremities evaluated using cone-beam CT. J Radiat Oncol. 2013;2:55\u201362.","journal-title":"J Radiat Oncol"},{"issue":"3","key":"2186_CR9","first-page":"223","volume":"41","author":"JY Zhang","year":"2019","unstructured":"Zhang JY, Yu XD, Song Y, et al. Comparison of imaging and pathologic findings of retroperitoneal dedifferentiated liposarcoma. Chin J Oncol. 2019;41(3):223\u20138.","journal-title":"Chin J Oncol"},{"issue":"6","key":"2186_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3390\/diseases13060177","volume":"13","author":"GF Papalia","year":"2025","unstructured":"Papalia GF, De Marco G, Luciano C, et al. Evaluation of prognostic factors in myxoid liposarcoma treated with combined neoadjuvant radiotherapy and surgical excision: systematic review. Diseases. 2025;13(6):177.","journal-title":"Diseases"},{"issue":"2","key":"2186_CR11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/01.sla.0000108670.31446.54","volume":"239","author":"I Hassan","year":"2004","unstructured":"Hassan I, Park SZ, Donohue JH, et al. Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience. Ann Surg. 2004;239(2):244\u201350.","journal-title":"Ann Surg"},{"key":"2186_CR12","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1245\/s10434-010-1057-5","volume":"17","author":"S Bonvalot","year":"2010","unstructured":"Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol. 2010;17:1507\u201314.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"2186_CR13","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/bjs.6994","volume":"97","author":"DC Strauss","year":"2010","unstructured":"Strauss DC, Hayes AJ, Thway K, et al. Surgical management of primary retroperitoneal sarcoma. Br J Surg. 2010;97(5):698\u2013706.","journal-title":"Br J Surg"},{"issue":"7","key":"2186_CR14","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1245\/s10434-023-13314-9","volume":"30","author":"L Improta","year":"2023","unstructured":"Improta L, Pasquali S, Iadecola S, et al. Organ infiltration and patient risk after multivisceral surgery for primary retroperitoneal liposarcomas. Ann Surg Oncol. 2023;30(7):4500\u201310.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2186_CR15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3390\/curroncol30010039","volume":"30","author":"SM Ruf","year":"2022","unstructured":"Ruf SM, Grignol VP, Contreras CM, et al. Morbidity and mortality after surgery for retroperitoneal sarcoma. Curr Oncol. 2022;30(1):492\u2013505.","journal-title":"Curr Oncol"},{"issue":"7","key":"2186_CR16","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s10147-024-02530-2","volume":"29","author":"G Xue","year":"2024","unstructured":"Xue G, Wang Z, Liu B, et al. Short-and long-term post-nephrectomy outcomes for retroperitoneal liposarcoma from a high-volume sarcoma center: a propensity score matching analysis. Int J Clin Oncol. 2024;29(7):1035\u201343.","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"2186_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1053\/j.semdp.2019.02.006","volume":"36","author":"K Thway","year":"2019","unstructured":"Thway K. Well-differentiated liposarcoma and dedifferentiated liposarcoma: an updated review. Semin Diagn Pathol. 2019;36(2):112\u201321.","journal-title":"Semin Diagn Pathol"},{"issue":"1","key":"2186_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00345-024-05389-0","volume":"43","author":"J Mercier","year":"2024","unstructured":"Mercier J, Br\u00e9hat \u00c9, Ghouti L, et al. Potential benefits of neoadjuvant radiotherapy prior to en bloc compartmental resection of pure retroperitoneal liposarcomas. World J Urol. 2024;43(1):40.","journal-title":"World J Urol"},{"issue":"1","key":"2186_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/jso.24927","volume":"117","author":"MY Zaidi","year":"2018","unstructured":"Zaidi MY, Canter R, Cardona K. Post-operative surveillance in retroperitoneal soft tissue sarcoma: the importance of tumor histology in guiding strategy. J Surg Oncol. 2018;117(1):99\u2013104.","journal-title":"J Surg Oncol"},{"issue":"25","key":"2186_CR20","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1200\/JCO.2012.46.5740","volume":"31","author":"A Gronchi","year":"2013","unstructured":"Gronchi A, Miceli R, Shurell E, et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol. 2013;31(25):3133\u201340.","journal-title":"J Clin Oncol"},{"issue":"12","key":"2186_CR21","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/dc.21794","volume":"40","author":"LG Dodd","year":"2012","unstructured":"Dodd LG. Update on liposarcoma: a review for cytopathologists. Diagn Cytopathol. 2012;40(12):1122\u201331.","journal-title":"Diagn Cytopathol"},{"issue":"5","key":"2186_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/SLA.0000000000000978","volume":"260","author":"MK Angele","year":"2014","unstructured":"Angele MK, Albertsmeier M, Prix NJ, et al. Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study. Ann Surg. 2014;260(5):749\u201356.","journal-title":"Ann Surg"},{"issue":"6","key":"2186_CR23","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.ejso.2022.02.016","volume":"49","author":"M Baia","year":"2023","unstructured":"Baia M, Ford SJ, Dumitra S, et al. Follow-up of patients with retroperitoneal sarcoma. Eur J Surg Oncol. 2023;49(6):1125\u201332.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"2186_CR24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12894-022-01128-y","volume":"22","author":"X Lyu","year":"2022","unstructured":"Lyu X, et al. Robot-assisted partial nephrectomy: can retroperitoneal approach suit for renal tumors of all locations?\u2014a large retrospective cohort study. BMC Urol. 2022;22(1):202.","journal-title":"BMC Urol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02186-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02186-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02186-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:16:07Z","timestamp":1784067367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02186-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2186"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02186-2","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective case report was reviewed and approved by the Ethics Committee of the Affiliated Hangzhou First People\u2019s Hospital, Westlake University School of Medicine, Institutional Review Board (Number of approval: MR-33-25-089275). The operation was performed in August 2024, and the retrospective data analysis and manuscript writing were approved by the ethics committee in 2025. This study was conducted in strict accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of this case report and accompanying images was obtained from the patient. All personal identifiers have been anonymized to protect patient privacy.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"160"}}